首页> 外文OA文献 >Effects of amlodipine and lacidipine on cardiac remodelling and renin production in salt-loaded stroke-prone hypertensive rats
【2h】

Effects of amlodipine and lacidipine on cardiac remodelling and renin production in salt-loaded stroke-prone hypertensive rats

机译:氨氯地平和拉米地平对易发盐盐性卒中高血压大鼠心脏重塑和肾素生成的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Calcium channel blockers (CCBs) are anti-hypertensive drugs that are usually considered to act mainly as vasodilators. We investigated the relation between the reduction of blood pressure evoked by two long-acting CCBs and their protective effect against cardiac and renal damage in salt-loaded stroke-prone spontaneously hypertensive rats (SHRSP).SHRSP were exposed to high dietary salt intake (1% NaCl in drinking solution) from 8 to 14 weeks of age, with or without amlodipine or lacidipine at three dosage regimens producing similar effects on blood pressure.The lowest dosages of both drugs had non-significant effects on blood pressure but inhibited the paradoxical increases in plasma renin activity (PRA) and in renin mRNA in kidney that were found in salt-loaded SHRSP. The lowest dosage of lacidipine (but not of amlodipine) restored the physiological downregulation of renin production by high salt and reduced left ventricular hypertrophy and mRNA levels of atrial natriuretic factor and transforming growth factor-β1.The intermediate dosages reduced blood pressure and PRA in a comparable manner, but cardiac hypertrophy was more reduced by lacidipine than by amlodipine.Although the highest doses exhibited a further action on blood pressure, they had no additional effect on cardiac hypertrophy, and they increased PRA and kidney levels of renin mRNA even more than in the absence of drug treatment.We conclude that reduction of blood pressure is not the sole mechanism involved in the prevention of cardiac remodelling by CCBs, and that protection against kidney damage and excessive renin production by low and intermediate dosages of these drugs contributes to their beneficial cardiovascular effects.
机译:钙通道阻滞剂(CCB)是抗高血压药,通常被认为主要起血管扩张剂的作用。我们研究了两种长效CCB引起的血压降低与其对盐易中风自发性高血压大鼠(SHRSP)对心脏和肾脏损害的保护作用之间的关系.SHRSP暴露于高盐饮食中(1 8至14周龄的饮用溶液中的NaCl百分比),有或没有氨氯地平或拉西地平三种剂量方案对血压产生相似的影响。两种药物的最低剂量对血压无明显影响,但抑制了矛盾的增加盐负荷的SHRSP中发现的血浆肾素活性(PRA)和肾脏中的肾素mRNA水平下降。最低剂量的拉西地平(但不是氨氯地平)可通过高盐恢复肾素的生理下调,并减少左心室肥大和心房利钠因子和转化生长因子-β1的mRNA水平。相似的方法,但是拉西地平比氨氯地平对心脏肥大的抑制作用更大。尽管最高剂量对血压有进一步的作用,但它们对心脏肥大没有附加作用,它们使PRA和肾素的肾素mRNA的增加甚至超过我们得出的结论是,降低血压不是CCB预防心脏重塑的唯一机制,低剂量和中等剂量的这些药物对肾脏损害和过多的肾素生成的保护作用有助于它们的有益作用。心血管作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号